Para visualizar nuestra web en la versión de Español, haga click Aquí . To view our website in the Spanish version, click Here

NEW CHEWABLE SOFT TABLETS THAT ELIMINATE ECTOPARASITES FAST, EFFECTIVELY AND SAFELY.

We innovate in the use of Fluralaner to give you the freedom to choose the most convenient treatment. Choose between: ATREVIA® One for 1 month of protection or ATREVIA® XR for 3 months.

1 MONTH OF PROTECTION

FLEAS

TICKS

MITES

First monthly administration fluralaner in our market


mini 2-4.5 kg	small 4.5-10 kg	medium 10-20 kg	large 20-40 kg
50 mg FLURALANER (mg per tablet)	100 mg FLURALANER (mg per tablet)	200 mg FLURALANER (mg per tablet)	400 mg FLURALANER (mg per tablet)
Download	Download	Download	Download

For dogs weighing more than 40 kg, administer a suitable combination. The tablets are protected by a unitarily sealed aluminum blister.

* It is recommended to dose with food. Atrevia® One protects for 1 month.

3 MONTHS OF PROTECTION

FLEAS

TICKS

MITES

Sustained action for up to 14 weeks in field tests


mini 2-4.5 kg	small 4.5-10 kg	medium 10-20 kg	large 20-40 kg
125 mg FLURALANER (mg per tablet)	250 mg FLURALANER (mg per tablet)	500 mg FLURALANER (mg per tablet)	1000 mg FLURALANER (mg per tablet)
Download	Download	Download	Download

For dogs weighing more than 40 kg, administer a suitable combination. The tablets are protected by a unitarily sealed aluminum blister.

* It is recommended to dose with food. Atrevia® XR protects for 3 months.

CHOOSE AN IRRESISTIBLE PROTECTION: ATREVIA® ONE FOR ONE MONTH OF PROTECTION AND ATREVIA® XR FOR THREE MONTHS

CONVENIENCE

Choose the most convenient treatment for your patients. Atrevia® One for monthly protection or Atrevia® XR for 3 months of sustained protection against ectoparasites.

FAST AND EFFECTIVE

Atrevia® XR acts from the 90th minute against fleas(1), reaching 99% effectiveness at 8 hours after administration(2).

IRRESISTIBLE PROTECTION

Atrevia® has high palatability and acceptance. Acoording to fleas studies, it has a voluntary consumption of 95.65%(3).

BROAD SPECTRUM AND ENVIRONMENTAL CONTROL

Atrevia® XR is lethal against fleas, ticks, and scabies mites. Its continuous use helps to control inmature stages.

HEALTHIER SKIN

Complete recovery in cases of scabies, and the perfect complement for the treatment against flea allergy dermatitis (FAD).

SAFETY

Safe in lactating females, puppies from the 8th week and/or 2 kg of weight, dogs with MDR1 GEN mutation, and other breeds sensitive to macrocyclic lactones. No serious adverse reactions or neurological reactions have ocurred during the studies.

INNOCUITY

The systemic action of Atrevia® allows protection without exposing families to insecticides as in topical formulations.

WATERRESISTANT

Due to its administration route, it can be used the same bath day. Its efficacy is not diminished by the contact of the pet with water.

EXCLUSIVE USE IN DOGS

View technical information

Fleas

Immediate and prolonged action

Atrevia® rapidly eliminates fleas within 90 minutes of administration. It is effective against Ctenocephalides felis and Ctenocephalides canis infestations. It provides environmental control, avoiding reinfestations.

Performance Atrevia® One¹

100% flea elimination at 8 hours after administration, maintaining sustained effectiveness for 28 days after dosing (6).

Download the study here

Performance Atrevia® XR²

Atrevia® XR exhibits lethal activity for at least 98 days against fleas. This contributes to a better environmental control, maintaining the same activity as the reference product on the market (2).

Download the study here

Ticks

An enemy without time left

Atrevia® One has action against adult and immature form of Rhipicephalus sanguineus, Ixodes spp. and Dermacentor reticulatus and Dermacentor variabilis. Its use prevents vector-borne diseases, such as erhlichiosis, babesiosis, anaplasmosis and others.

Performance Atrevia® One

Action higher than 87% in the elimination of ticks within the first 8 hours, reaching 100% effectiveness on day 14, which is prolonged until day 28 (5).

Download the study here

Performance Atrevia® XR

Atrevia® XR maintains persistent activity for up to 14 weeks (day 98) against ticks. Studies support the effectiveness of Atrevia® in comparison with other reference products on the market (5).

Download the study here

Mites

The definitive end for scabies

Atrevia® One is great for the control of dermatological problems caused by Demodex canis, Sarcoptes scabiei var. canis and Otodectes cynotis. Our field studies support its effectiveness in controlling the associated clinical signs: plaques, scales, crusts, comedones, papules, pustules, alopecia and erythema.

Performance Atrevia® XR

Sarna Demodéctica

A single dose of Atrevia® XR allowed the resolution of 100% of demodicosis cases from day 42, after administration (6).

Download the study here

Sarna Sarcóptica

Atrevia® XR achieved 90 % effectiveness on day 98 after administration. Most cases of scabies can be resolved with a single dose (6).

Download the study here

Performance Atrevia® One¹

Sarna Demodéctica

It reached an effectiveness higher than 50% on day 28, two weeks after receiving the 2nd dose, and on day 98; after 3 dosages every 28 days, complete recovery of the cases was obtained (6).

Download the study here

Sarna Sarcóptica

The effectiveness achieved was higher than 60% after the 2nd dosage. Total recovery of the treated cases was obtained in the third dosage (6).

Download the study here

High Palatability

Palatability of Atrevia® XR and Atrevia® ONE

Atrevia® has a high palatability and acceptance. According to field studies, it has a voluntary consumption of 98%.

Score	Quantity	Percentage
0	8	1.11%
1	7	0.97%
2	12	1.67%
3	693	96.25%

Score: Score: 0 Animal should be forced to eat the tablet 1 Animal shows interest initially, but should be forced to eat the tablet 2 Animal shows interest and eats the tablet when it is placed on its snout 3 Animal smells the tablet and eats it voluntarily

Protection proven by field studies under real life conditions

ACTION ONSET - Atrevia® XR

Atrevia® XR achieved 100% fleas elimination at 8 hours after administration, maintaining sustained efficacy for 28 days after dosing(1).

	Counting basal	90'	120'	180'	240'
Media (Median)	185(179)	0.83(1)	9.83(9.5)	30(29.5)	84(89.5)
Range of counting	95-261	0-2	2-19	19-42	38-114
Effectiveness		0.45%	5.32%	16.22%	45.41%

Start of activity

Average: 91' Range: 88'- 98'

QUICK ACTION ONSET - Atrevia® ONE

Atrevia® One starts to eliminate fleas from the 90th minute after administration. The table describes the progression during the first 4 action hours the product. The baseline count is given for reference.

	Counting basal	90'	120'	180'	240'
Media (Median)	142.67(136.5)	0.67(0.5)	10.67(11.5)	25.83(25)	63.5(54.5)
Range of counting	87-238	0-2	1-21	14-43	48-101
Effectiveness		0.47%	7.48%	18.11%	44.51%

Start of activity

Average: 91' Range: 89'- 93'

PROVEN SAFETY

Field tests confirm the safety of Atrevia® One and Atrevia® XR in dogs. Learn more about these studies, clic here.

LEARN MORE ABOUT OUR SUPERCHEWS™

Exclusive technology developed by Agrovet Market for the production of chewable tablets.

SOFT CONSISTENCY
Softer consistency compared to other products.
ATTRACTIVE SMELL AND TASTE
Exclusive blend of flavorings, which masks the taste of the active ingredients.
HIGH ACCEPTANCE
Studies support its high acceptance with a voluntary consumption of 98% in treated dogs.

TOTAL DISINTEGRATION
Proprietary association of two synergistic disintegrants, facilitates disintegration of the tablets.
CONVENIENCE
Easy administration in dogs with oral problems or reluctant to take medication.
DIVERSITY
Tablets in different sizes according to weight range.

LEARN MORE ABOUT OUR SUPERCHEWS™

Exclusive technology developed by Agrovet Market for the production of chewable tablets.

SOFT CONSISTENCY

Softer consistency compared to other products.

ATTRACTIVE SMELL AND TASTE

Exclusive blend of flavorings, which masks the taste of the active ingredients.

HIGH ACCEPTANCE

Studies support its high acceptance with a voluntary consumption of 98% in treated dogs.

TOTAL DISINTEGRATION

Proprietary association of two synergistic disintegrants, facilitates disintegration of the tablets.

CONVENIENCE

Easy administration in dogs with oral problems or reluctant to take medication.

DIVERSITY

Tablets in different sizes according to weight range.

Chávez L. 2021. Evaluación del tiempo de inicio de actividad pulguicida de una formulación oral a base de fluralaner de aplicación mensual en caninos.
Chávez L., Liao V. 2021. Evaluación de la efectividad, tolerancia y residualidad de una formulación oral a base de fluralaner de aplicación mensual y una formulación oral a base de sarolaner de aplicación mensual para el tratamiento y control de pulgas en caninos naturalmente infestados.
Chávez L., Liao V. 2021. Evaluación de la palatabilidad de una tableta masticable a base de fluralaner de aplicación mensual en caninos.
Chávez L., Liao V. 2021.Evaluación de la seguridad de una formulación oral a base de fluralaner de aplicación mensual en caninos.
Chávez L., Liao V. 2021. Evaluación de la efectividad, tolerancia y residualidad de una formulación oral a base de fluralaner de aplicación mensual y una formulación oral a base de sarolaner de aplicación mensual para el tratamiento y control de garrapatas en caninos naturalmente infestados.
Chávez L., Liao V. 2021. Evaluación de la efectividad, tolerancia y residualidad de una formulación oral a base de fluralaner de aplicación mensual y una formulación oral a base de sarolaner de aplicación mensual para el tratamiento y control de ácaros y la reducción de sus signos clínicos en caninos.

Hello, vet!

If you are interested in Atrevia® One and Atrevia® XR, contact us through this form

I want to appear as a point of sale for Atrevia®

YES

I accept the terms and conditions

I accept the Personal Data Processing Policy

Materials for veterinarians

In this section you can find graphic and audiovisual documents with research and field studies that support the effectiveness of Atrevia®. Learn much more about our products!

brochure

Brochure Atrevia® XR

Petmedica

Download

brochure

Brochure Atrevia® One

Petmedica

Download

estudio

PALATABILITY REPORT ATREVIA® XR

Author: Luis Chávez, Valeria Liao

Download

estudio

PALATABILITY REPORT ATREVIA® ONE

Author: Luis Chávez, Valeria Liao

Download

estudio

ACTION ONSET REPORT ATREVIA® XR

Author: Luis Alfredo Chávez Balarezo

Download

View all materials

Atrevia, an effective and irresistible protection

Introducing an irresistible protection

Choose the most convenient treatment

ATREVIA® One - 1 month

ATREVIA® XR - 3 months

NEW CHEWABLE SOFT TABLETS THAT ELIMINATE ECTOPARASITES FAST, EFFECTIVELY AND SAFELY.

mini

small

medium

large

mini

small

medium

large

CHOOSE AN IRRESISTIBLE PROTECTION: ATREVIA® ONE FOR ONE MONTH OF PROTECTION AND ATREVIA® XR FOR THREE MONTHS

CONVENIENCE

FAST AND EFFECTIVE

IRRESISTIBLE PROTECTION

BROAD SPECTRUM AND ENVIRONMENTAL CONTROL

HEALTHIER SKIN

SAFETY

INNOCUITY

WATERRESISTANT

Fleas

Performance Atrevia® One¹

Performance Atrevia® XR²

Ticks

Performance Atrevia® One

Performance Atrevia® XR

Mites

Performance Atrevia® XR

Sarna Demodéctica

Sarna Sarcóptica

Performance Atrevia® One¹

Sarna Demodéctica

Sarna Sarcóptica

High Palatability

Protection proven by field studies under real life conditions

LEARN MORE ABOUT OUR SUPERCHEWS™

LEARN MORE ABOUT OUR SUPERCHEWS™

SOFT CONSISTENCY

ATTRACTIVE SMELL AND TASTE

HIGH ACCEPTANCE

TOTAL DISINTEGRATION

CONVENIENCE

DIVERSITY

Hello, vet!

Materials for veterinarians

Brochure Atrevia® XR

Brochure Atrevia® One

PALATABILITY REPORT ATREVIA® XR

PALATABILITY REPORT ATREVIA® ONE

ACTION ONSET REPORT ATREVIA® XR